94 related articles for article (PubMed ID: 1469744)
1. Neuromuscular junctions contain NP185: the multifunctional protein is located at the presynaptic site.
Perry DG; Li S; Hanson V; Puszkin S
J Neurosci Res; 1992 Nov; 33(3):408-17. PubMed ID: 1469744
[TBL] [Abstract][Full Text] [Related]
2. Neuronal specific protein NP185 is enriched in nerve endings: binding characteristics for clathrin light chains, synaptic vesicles, and synaptosomal plasma membrane.
Su B; Hanson V; Perry D; Puszkin S
J Neurosci Res; 1991 Aug; 29(4):461-73. PubMed ID: 1791638
[TBL] [Abstract][Full Text] [Related]
3. Neuronal protein NP185 is developmentally regulated, initially expressed during synaptogenesis, and localized in synaptic terminals.
Puszkin S; Perry D; Li S; Hanson V
Mol Neurobiol; 1992; 6(2-3):253-83. PubMed ID: 1476676
[TBL] [Abstract][Full Text] [Related]
4. Neuronal protein NP185 in avian and murine cerebellum: expression during development and evidence for its presence in nerve endings.
Perry DG; Hanson V; Benuck ML; Puszkin S
J Histochem Cytochem; 1991 Nov; 39(11):1461-70. PubMed ID: 1918924
[TBL] [Abstract][Full Text] [Related]
5. A novel AP180-related protein in vesicles that concentrate at acetylcholine receptor clusters.
Bursztajn S; Vincent S; Brodsky FM; Benes F; Morris SA
J Cell Biochem; 1998 Mar; 68(4):457-71. PubMed ID: 9493909
[TBL] [Abstract][Full Text] [Related]
6. A neuronal protein (NP185) associated with clathrin-coated vesicles. Characterization of NP185 with monoclonal antibodies.
Kohtz DS; Puszkin S
J Biol Chem; 1988 May; 263(15):7418-25. PubMed ID: 2452823
[TBL] [Abstract][Full Text] [Related]
7. Differential distribution of vesicular carriers during differentiation and synapse formation.
Bursztajn S; Jong YJ; Berman SA
J Cell Biochem; 1993 Nov; 53(3):251-64. PubMed ID: 8263042
[TBL] [Abstract][Full Text] [Related]
8. Neural agrin increases postsynaptic ACh receptor packing by elevating rapsyn protein at the mouse neuromuscular synapse.
Brockhausen J; Cole RN; Gervásio OL; Ngo ST; Noakes PG; Phillips WD
Dev Neurobiol; 2008 Aug; 68(9):1153-69. PubMed ID: 18506821
[TBL] [Abstract][Full Text] [Related]
9. Palisade endings: cholinergic sensory organs or effector organs?
Blumer R; Konakci KZ; Pomikal C; Wieczorek G; Lukas JR; Streicher J
Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1176-86. PubMed ID: 18936148
[TBL] [Abstract][Full Text] [Related]
10. In vivo observations of pre- and postsynaptic changes during the transition from multiple to single innervation at developing neuromuscular junctions.
Balice-Gordon RJ; Lichtman JW
J Neurosci; 1993 Feb; 13(2):834-55. PubMed ID: 8426240
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of agrin isoforms in Xenopus embryos alters the distribution of synaptic acetylcholine receptors during development of the neuromuscular junction.
Godfrey EW; Roe J; Heathcote RD
Dev Biol; 1999 Jan; 205(1):22-32. PubMed ID: 9882495
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of tubulin by casein kinase II regulates its binding to a neuronal protein (NP 185) associated with brain coated vesicles.
Kohtz DS; Puszkin S
J Neurochem; 1989 Jan; 52(1):285-95. PubMed ID: 2562810
[TBL] [Abstract][Full Text] [Related]
13. High-resolution localization of clathrin assembly protein AP180 in the presynaptic terminals of mammalian neurons.
Yao PJ; Coleman PD; Calkins DJ
J Comp Neurol; 2002 May; 447(2):152-62. PubMed ID: 11977118
[TBL] [Abstract][Full Text] [Related]
14. Purification and molecular characterization of NP185, a neuronal-specific and synapse-enriched clathrin assembly polypeptide.
Li S; Lisanti M; Puszkin S
Bioquim Patol Clin; 1998; 62(1):5-17. PubMed ID: 31402847
[TBL] [Abstract][Full Text] [Related]
15. A light and electron microscopic study of dystrophin localization at the mouse neuromuscular junction.
Huard J; Fortier LP; Dansereau G; Labrecque C; Tremblay JP
Synapse; 1992 Feb; 10(2):83-93. PubMed ID: 1585259
[TBL] [Abstract][Full Text] [Related]
16. Plastic-embedded semithin cross-sections as a tool for high-resolution immunofluorescence analysis of the neuromuscular junction molecules: Specific cellular location of protease-activated receptor-1.
Lanuza MA; Besalduch N; Garcia N; Sabaté M; Santafé MM; Tomàs J
J Neurosci Res; 2007 Mar; 85(4):748-56. PubMed ID: 17265467
[TBL] [Abstract][Full Text] [Related]
17. Is dystrophin present in the nerve terminal at the neuromuscular junction? An immunohistochemical study of the heterozygote dystrophic (mdx) mouse.
Huard J; Fortier LP; Labrecque C; Dansereau G; Tremblay JP
Synapse; 1991 Feb; 7(2):135-40. PubMed ID: 2011828
[TBL] [Abstract][Full Text] [Related]
18. Defects in neuromuscular junction structure in dystrophic muscle are corrected by expression of a NOS transgene in dystrophin-deficient muscles, but not in muscles lacking alpha- and beta1-syntrophins.
Shiao T; Fond A; Deng B; Wehling-Henricks M; Adams ME; Froehner SC; Tidball JG
Hum Mol Genet; 2004 Sep; 13(17):1873-84. PubMed ID: 15238508
[TBL] [Abstract][Full Text] [Related]
19. AP-3: an adaptor-like protein complex with ubiquitous expression.
Dell'Angelica EC; Ohno H; Ooi CE; Rabinovich E; Roche KW; Bonifacino JS
EMBO J; 1997 Mar; 16(5):917-28. PubMed ID: 9118953
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor binding protein-1 at mouse neuromuscular synapses.
Ma J; Yang SX; Ho GJ; Festoff BW
Synapse; 1994 Aug; 17(4):225-9. PubMed ID: 7527601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
